4C LABS
Gregory Dobbin is an experienced executive in various industries, currently serving as the Chief Executive Officer at 4C LABS, a pharmaceutical products manufacturer, since February 2018. Prior to this role, Gregory was the Chief Operating Officer at MJZ from January 1999 to January 2018, where work encompassed all aspects of commercial film production for high-profile clients such as VISA, Google, and Pfizer. Gregory co-founded Extremely Canadian, a tour and travel company, from January 1995 to December 1998, and previously held the position of Logistics Supervisor and Project Manager at Quetrek Freight, focusing on the logistics of over-dimensional equipment for mining projects in North America. Gregory holds a Bachelor of Business Administration degree from Bishop's University, earned between 1987 and 1991.
This person is not in any teams
4C LABS
4C LABS is a rapidly scaling healthcare, technology and pharmaceutical start-up focused on virtual prescribing, pharmaceutical distribution and clinical development in cannabis based medicinal products for human health. The empirical evidence for the efficacy of CBPM's as a therapeutic agent in the treatment of cancer related pain, anxiety, childhood epilepsy, spasticity and sleep disorders is now overwhelming. We are committed to advancing scientific research, as well as enabling the regulation, distribution and prescribing of CBPM's in the UK and Channel Islands. Our work with leading scientists, specialist physicians and pharmacists is underpinned with disruptive technologies that are driving an approach to treatment that prioritizes patients and evidence over stigma. We work closely with Drug Science, the Cannabis Industry Council, The Home Office, The Medicines and Healthcare and regulatory Authority and the Care Quality Commission to catalyse safe, regulated change in the medical landscape. If you are a technologist, physician, scientist, distributor, LP or a patient and are interested in working with us, get in touch for a conversation: info@4clabs.ca